ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 715,97
0,35%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Portola Pharmaceuticals Inc (PTLA)

  7. Portola Pharmaceuticals Inc (PTLA) Actualités

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
13/07/202014h30Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PTLAPortola Pharmaceuticals Inc
07/07/202021h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
02/07/202020h33Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:PTLAPortola Pharmaceuticals Inc
02/07/202020h33Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PTLAPortola Pharmaceuticals Inc
02/07/202020h32Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:PTLAPortola Pharmaceuticals Inc
02/07/202020h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
25/06/202015h28Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
25/06/202015h27Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
09/06/202016h05Edgar (US Regulatory)Schedule 13gNASDAQ:PTLAPortola Pharmaceuticals Inc
08/06/202020h57Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
27/05/202014h52Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:PTLAPortola Pharmaceuticals Inc
27/05/202014h03Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:PTLAPortola Pharmaceuticals Inc
26/05/202012h09Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PTLAPortola Pharmaceuticals Inc
18/05/202022h29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
18/05/202022h02PR Newswire (US)Portola Pharmaceuticals Announces Virtual 2020 Annual Stockholder MeetingNASDAQ:PTLAPortola Pharmaceuticals Inc
15/05/202019h20PR Newswire (US)INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Enco...NASDAQ:PTLAPortola Pharmaceuticals Inc
14/05/202014h00PR Newswire (US)U.S. Centers for Medicare & Medicaid Services (CMS) Proposes Extending New Technology Add-on Payment (NTAP) Reimbursement for...NASDAQ:PTLAPortola Pharmaceuticals Inc
11/05/202022h12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTLAPortola Pharmaceuticals Inc
11/05/202014h00PR Newswire (US)Portola Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
08/05/202015h58Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PTLAPortola Pharmaceuticals Inc
07/05/202023h19Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PTLAPortola Pharmaceuticals Inc
06/05/202002h02PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Portola Pharmaceuticals, Inc.NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/202022h02PR Newswire (US)Portola Pharmaceuticals Cancels First Quarter 2020 Financial Results Webcast and Conference Call Following Agreement to be Ac...NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/202021h10PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Portola Pharmaceuticals, Inc.NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/202020h23PR Newswire (US)Moore Kuehn Encourages TORC, STML, KLXE, and PTLA Investors to Contact Law FirmNASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/202018h39PR Newswire (US)Portola Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Portola Pharmaceuticals, Inc....NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/202016h48PR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Portola Pharmaceuticals, Inc. has obtained a Fair Price in its...NASDAQ:PTLAPortola Pharmaceuticals Inc
01/05/202022h23PR Newswire (US)Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:PTLAPortola Pharmaceuticals Inc
23/04/202022h21PR Newswire (US)Portola Pharmaceuticals to Announce First Quarter 2020 Financial Results on Monday, May 11, 2020NASDAQ:PTLAPortola Pharmaceuticals Inc
20/04/202023h05Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA

Dernières Valeurs Consultées

BIT
UC8FSJ
Unicredit Bank
USOTC
TCISF
Tachi S (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés